Pre-appointment hearing with the Government’s preferred candidate for Chair of the Financial Reporting Council Contents

Appendix 3: Candidate CV

Simon was until recently the Chief Financial Officer and a member of the Main Board of GlaxoSmithKline plc. He stepped down in May 2019 after over 8 years with the company. During his time with GSK, he provided operational and financial leadership through a period of significant business transformation including extensive restructuring and the strategic re-shaping of the group and its three global businesses: Pharmaceuticals, Vaccines and Consumer Healthcare, which together employ nearly 100,000 people.

As part of his role at GSK, Simon was directly responsible for Global Finance and several of the company’s other key support functions including Technology, Data and Analytics. He led a number of significant operational change programmes for the company including extensive restructuring, capital investments and technology and systems upgrades. He also drove a number of major strategic transactions.

These included a three-way asset swap with Novartis, a consumer JV with Pfizer and the acquisition of a key oncology platform to strengthen GSK’s pharmaceuticals pipeline.

Simon joined GSK in 2011 from Goldman Sachs International where he was a Managing Director and Partner.

Simon has been a Trustee of the Donmar Theatre since 2018 and also served as Chairman of the 100 Group of Finance Directors between 2014 and 2016. He has a Masters Degree in Geography from Oxford.

Career Highlights and Experience:

Chief Financial Officer & Main Board Director, GlaxoSmithKline plc

Jan 2011-May 2019

Partner & Managing Director, Goldman Sachs International

Jan 1996-Dec 2010

Director, S.G. Warburg & Co.

Sep 1985-Dec 1995

Published: 22 July 2019